WebAnnual Financial Report - DiaSorin WebDiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics and …
DiaSorin S.p.A Revenue 2024-2024 DSRLF MacroTrends
WebJan 15, 2024 · Press Release Saluggia , January 15th, 2024 DIASORIN S.P.A. 2024 ANNUAL CALENDAR OF CORPORATE EVENTS* ... April 1, 2024 WebMay 6, 2024 · Source: annual report Luminex Corp. FY 2024 In its press release, DiaSorin confirmed it expects to generate $55M in synergy benefits and I will assume these … share price edf energy
DIASORIN TO ACQUIRE LUMINEX C APPROXIMATELY USD …
WebSubscribe. Our Investor Relations department intends to provide analysts and investors, be they institutional or retail, actual or potential, with access to simple, exhaustive corporate information, the better to enable them … WebFiscal year is January-December. All values EUR Millions. 2024 2024 2024 2024 2024 5-year trend; Sales/Revenue: 1,238: 881: 706: 669: 637 WebAnnual Financial Report at December 31, 2024. pdf Download pdf 4.23MB; 2024. 14/08/2024. Half-Year Financial Report at June 30, 2024. pdf download file 1010.09KB; … Meet Our People - Annual & Interim Reports DiaSorin Saluggia (Italy), March 14, 2024 – The Board of Directors of DiaSorin S.p.A. … Presentations - Annual & Interim Reports DiaSorin Stock Price - Annual & Interim Reports DiaSorin The DiaSorin Leadership Model is the basis of our culture that guides and inspires … DiaSorin releases an updated Simplexa™ SARS-CoV-2 Variants Direct molecular … Group - Annual & Interim Reports DiaSorin Image Gallery - Annual & Interim Reports DiaSorin 2024. DiaSorin signs an exclusive license agreement with TTP for the … Work With Us - Annual & Interim Reports DiaSorin share price ekf diagnostics